Position in LH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$99,686,085
+$53,273,285 QoQ
Shares Held
373,622
+102.0% QoQ
Ownership
0.461%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $929,620,379 across 10 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
401,082 | $211,145,608 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
376,071 | $188,546,956 | |
| 3 | A |
Agilent Technologies, Inc.
|
814,971 | $108,252,597 | |
| 4 | ILMN |
Illumina, Inc.
|
581,730 | $102,285,585 | |
| 5 | GH |
Guardant Health, Inc.
|
647,818 | $97,192,134 | |
| 6 | RDNT |
RadNet, Inc.
|
1,171,721 | $72,260,034 | |
| 7 | DHR |
Danaher Corp /De/
|
310,000 | $59,048,800 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
235,000 | $53,295,650 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,686,085 | 373,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,412,800 | 185,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $936,389 | 3,262 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $117,977,769 | 449,422 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $119,821,068 | 514,828 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $101,881,830 | 444,278 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $103,993,512 | 465,337 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $81,356,989 | 399,769 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||